tiprankstipranks
Trending News
More News >
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market

West Pharmaceutical Services (WST) Ratios

Compare
766 Followers

West Pharmaceutical Services Ratios

WST's free cash flow for Q1 2025 was $0.33. For the 2025 fiscal year, WST's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.79 2.88 3.70 2.93 2.73
Quick Ratio
2.11 2.24 2.90 2.30 2.09
Cash Ratio
0.88 1.27 1.72 1.28 1.22
Solvency Ratio
0.67 0.77 0.76 0.80 0.48
Operating Cash Flow Ratio
1.19 1.16 1.39 0.98 0.94
Short-Term Operating Cash Flow Coverage
-155.57 5.79 39.78 10.92 38.10
Net Current Asset Value
$ 577.00M$ 987.90M$ 987.60M$ 763.60M$ 434.40M
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.08 0.09 0.10 0.12
Debt-to-Equity Ratio
0.11 0.11 0.12 0.14 0.18
Debt-to-Capital Ratio
0.10 0.10 0.11 0.12 0.15
Long-Term Debt-to-Capital Ratio
0.07 0.02 0.07 0.08 0.12
Financial Leverage Ratio
1.36 1.33 1.35 1.42 1.51
Debt Service Coverage Ratio
-530.25 5.05 29.62 12.98 23.92
Interest Coverage Ratio
189.97 75.11 92.91 104.49 59.84
Debt to Market Cap
<0.01 <0.01 0.01 <0.01 0.01
Interest Debt Per Share
4.18 4.28 4.38 4.47 4.50
Net Debt to EBITDA
-0.25 -0.65 -0.65 -0.49 -0.55
Profitability Margins
Gross Profit Margin
34.51%38.28%39.36%41.52%35.76%
EBIT Margin
20.34%23.97%23.82%26.74%19.07%
EBITDA Margin
25.71%28.62%30.76%31.61%24.77%
Operating Profit Margin
19.70%22.92%25.43%26.57%18.95%
Pretax Profit Margin
20.24%23.66%23.55%26.45%18.69%
Net Profit Margin
17.03%20.12%20.30%23.37%16.13%
Continuous Operations Profit Margin
16.52%20.12%20.30%23.37%16.13%
Net Income Per EBT
84.15%85.01%86.17%88.37%86.27%
EBT Per EBIT
102.74%103.25%92.63%99.55%98.62%
Return on Assets (ROA)
13.52%15.50%16.20%19.97%12.39%
Return on Equity (ROE)
18.37%20.60%21.82%28.34%18.67%
Return on Capital Employed (ROCE)
18.43%21.41%23.69%27.66%17.77%
Return on Invested Capital (ROIC)
14.98%16.85%19.48%23.17%14.41%
Return on Tangible Assets
13.97%16.01%16.78%20.81%13.05%
Earnings Yield
2.06%2.27%3.35%1.90%1.65%
Efficiency Ratios
Receivables Turnover
5.24 5.76 5.69 5.79 5.57
Payables Turnover
7.92 7.51 8.13 7.13 6.47
Inventory Turnover
5.03 4.19 4.22 4.38 4.29
Fixed Asset Turnover
1.72 1.95 2.29 2.51 2.12
Asset Turnover
0.79 0.77 0.80 0.85 0.77
Working Capital Turnover Ratio
2.57 2.21 2.27 2.81 2.70
Cash Conversion Cycle
96.23 101.91 105.72 95.26 94.14
Days of Sales Outstanding
69.70 63.35 64.15 63.03 65.51
Days of Inventory Outstanding
72.63 87.15 86.48 83.41 85.04
Days of Payables Outstanding
46.10 48.60 44.91 51.19 56.40
Operating Cycle
142.33 150.50 150.63 146.45 150.54
Cash Flow Ratios
Operating Cash Flow Per Share
8.95 10.45 9.73 7.85 6.39
Free Cash Flow Per Share
3.79 5.58 5.91 4.44 4.03
CapEx Per Share
5.16 4.87 3.83 3.41 2.36
Free Cash Flow to Operating Cash Flow
0.42 0.53 0.61 0.57 0.63
Dividend Paid and CapEx Coverage Ratio
1.50 1.85 2.14 1.92 2.12
Capital Expenditure Coverage Ratio
1.73 2.15 2.54 2.30 2.71
Operating Cash Flow Coverage Ratio
2.16 2.51 2.28 1.80 1.45
Operating Cash Flow to Sales Ratio
0.23 0.26 0.25 0.21 0.22
Free Cash Flow Yield
1.16%1.58%2.51%0.95%1.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
48.53 44.09 29.89 52.73 60.48
Price-to-Sales (P/S) Ratio
8.26 8.87 6.07 12.32 9.75
Price-to-Book (P/B) Ratio
8.91 9.08 6.52 14.94 11.29
Price-to-Free Cash Flow (P/FCF) Ratio
86.51 63.12 39.85 105.55 70.23
Price-to-Operating Cash Flow Ratio
36.60 33.69 24.19 59.75 44.31
Price-to-Earnings Growth (PEG) Ratio
-3.13 31.58 -2.61 0.58 1.40
Price-to-Fair Value
8.91 9.08 6.52 14.94 11.29
Enterprise Value Multiple
31.90 30.35 19.07 38.49 38.83
Enterprise Value
23.73B 25.62B 16.93B 34.46B 20.65B
EV to EBITDA
31.90 30.35 19.07 38.49 38.83
EV to Sales
8.20 8.68 5.87 12.17 9.62
EV to Free Cash Flow
85.85 61.80 38.54 104.23 69.26
EV to Operating Cash Flow
36.32 32.99 23.39 59.00 43.70
Tangible Book Value Per Share
35.14 37.11 34.40 29.60 23.18
Shareholders’ Equity Per Share
36.74 38.78 36.09 31.39 25.09
Tax and Other Ratios
Effective Tax Rate
0.18 0.18 0.17 0.14 0.18
Revenue Per Share
39.63 39.70 38.80 38.06 29.05
Net Income Per Share
6.75 7.99 7.88 8.90 4.68
Tax Burden
0.84 0.85 0.86 0.88 0.86
Interest Burden
0.99 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.01 0.02
Income Quality
1.33 1.31 1.24 0.88 1.36
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis